Newgen Software Technologies Ltd Q4 FY2022 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/tabk394ymj6o5ru9edho3w1e.pdf

Key Takeaways


Cost Normalization & Margin Pressure

Virender Jeet: "We think the employee cost further to go up even coming in this year by a few more percentages, but over a longer period of time you are absolutely right, a lot of our growth has got very little to do with direct cost involvement as you are rightly saying around 50% of our revenue has got no direct costs. We should be able to expand the margin, but in the near term right now we are working on the new reality of normalizing costs across all channels, so there is going to be some more pressure on the employee cost side."

Revenue Mix Shift: Annuity & Subscription

Virender Jeet: "Our estimates are that next three to five years, our subscription revenue should hit more than 60%, 65% of our overall revenue, this is the one head which keeps on going at a higher pace than our growth rates and as we are reaching more and more for subscription and removing the license based business organically we should further escalate."

Geographic Performance: EMEA Outshines, US Stable ex One-Time

Virender Jeet: "You are right if you look at overall addressable market we are a small fraction of that but I do not think that that fraction will change unless you make a big dent in markets like US and Europe."

GSI Channel & Partner Strategy

Virender Jeet: "We have a responsibility also to invest for growth for the company and will continue to invest for growth and those investments would balance it. So you are right the margin expansion should happen through that as well, but for next year we do not think that the implementation will move so much to GSI that it will change the overall dynamics of the margin."

Investment Priorities: Sales & Marketing Over R&D

Virender Jeet: "Product company with always works with this hope that the hockey stick is just around the corner and I think the hockey stick has got nothing with margins if you look at the gross margin level we still operate around 70% gross margin, so which is as high as it gets, we can go up to 75% but I do not think that is worth it, but I think we are looking at growth coming from the top line and the expansion of the business and that is where we expect an hockey stick."

Product & Platform Developments


Guidance & Commitments

CommitmentSpecificsTimeline
PAT marginDeliver between 18% to 19%FY23
EBITDA marginAround 23%FY23
Attrition normalizationBring attrition down significantly from 30%+ levelsQ3, Q4 of FY23
Subscription revenue mixHit more than 60-65% of overall revenueNext 3-5 years
Backlog and ARR disclosureProvide backlog, deferred orders, and ARR for subscriptionNext 3-4 quarters
Sales & marketing costsReturn close to pre-pandemic levels of 25-30% of costsFY23 and beyond
R&D spendRemain around 10% of revenue, ranging 9.5% to 11%FY23 and next year
Cash deploymentDeploy ~₹460 crores for growth via inorganic and organic means; if excess remains, may increase dividend payoutsNext 1-2 years for dividend decision

Key Metrics

MetricQ4 FY22
Revenue₹232 cr, +16% YoY
FY22 revenue₹779 cr
EBITDA₹67 cr, stable
FY22 EBITDA₹195 cr, stable
Profit after tax₹57 cr
FY22 profit after tax₹164 cr, +30% YoY
PAT margin expectation (FY23)18% to 19%
EBITDA margin expectation (FY23)about 23%
Annuity revenue (FY22)₹456 cr, +18% YoY, 59% of overall revenue
Cloud and subscription revenue growth (FY22)23% YoY
Subscription revenue share (FY22)31% of total revenues
Gross marginaround 70%
Partner revenue share (FY22)roughly 23%, up from 17%–18% previous year
GSI funnel70 to 80 cases, up from around 40 cases last year-end
Customers with billing over ₹5 cr (FY22)38, up from 26 in FY21
New logos added (FY22)53
Active customersroughly 530, down from 550–560 range previously
Attrition (FY22)above 30%, may be touching close to 40%
Employee cost (FY22)53% of revenue, up from 49% last year
R&D expense (FY22)about 10% of revenue
Sales and marketing expense (FY22)20% of revenues
Cash, bank balance and investments₹462 cr
Net cash from operating activities (FY22)₹143 cr
Net trade receivables₹279 cr, net DSO of 131 days
Dividend payout ratio (FY22)45%
US one-time PPP revenue (FY21)₹25 cr, not repeated in FY22
EMEA segment growth (FY22)40% kind of growth
Intangible assets from Number Theory acquisition₹16 cr product valuation, ₹2.5 cr goodwill, amortized over 5 years